Cargando…

Alkaline phosphatase flare phenomenon following epidermal growth factor receptor-tyrosine kinase inhibitor treatment of non-small cell lung cancer: Report of a case and case review

Alkaline phosphatase (ALP) flare phenomenon documented as scintigraphic flare phenomenon due to elevated serum ALP levels produced by osteoblasts reflects an osteoblastic reaction in response to the effective therapy of non-small cell lung cancer (NSCLC). Here, we report a case of ALP flare followin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasuda, Yuko, Kawamura, Kodai, Ichikado, Kazuya, Yoshioka, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246355/ https://www.ncbi.nlm.nih.gov/pubmed/26029561 http://dx.doi.org/10.1016/j.rmcr.2014.09.003

Ejemplares similares

A Case of Orbital Metastasis as Disease Progression of Anaplastic Lymphoma Kinase-Positive Lung Cancer Treated with Crizotinib
por: Sakata, Yoshihiko, et al.
Publicado: (2015)

Reliability of Alkaline Phosphatase for Differentiating Flare Phenomenon from Disease Progression with Bone Scintigraphy
por: Jung, Ji-hoon, et al.
Publicado: (2022)

Hermansky–Pudlak syndrome type 4 with interstitial pneumonia
por: Sakata, Yoshihiko, et al.
Publicado: (2013)

The Alkaline Phosphatase Flare Phenomenon: A Transient Substantial Increase in Alkaline Phosphatase Concentration in a Prostate Cancer Patient after Starting GnRH Agonist Treatment
por: Merlo, Pierina, et al.
Publicado: (2021)

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
por: Kawamura, Kodai, et al.
Publicado: (2017)

Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease
por: Nitawaki, Tatsuya, et al.
Publicado: (2017)

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience
por: Kawamura, Kodai, et al.
Publicado: (2019)

Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
por: Kawamura, Kodai, et al.
Publicado: (2020)

Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon
por: Wang, Yong, et al.
Publicado: (2018)

Multinodular lung infiltrate in a patient with lymphoma: metastasis, tuberculosis or other?
por: Anan, Keisuke, et al.
Publicado: (2017)

Dendriform Pulmonary Ossification
por: Anan, Keisuke, et al.
Publicado: (2018)

Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Sakata, Yoshihiko, et al.
Publicado: (2019)

Correction: A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient
por: De Bondt, Charlotte, et al.
Publicado: (2020)

The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study
por: Takaki, Makoto, et al.
Publicado: (2017)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events
por: Sakata, Yoshihiko, et al.
Publicado: (2018)

Clinical characteristics and prognosis of drug-associated acute respiratory distress syndrome compared with non-drug-associated acute respiratory distress syndrome: a single-centre retrospective study in Japan
por: Anan, Keisuke, et al.
Publicado: (2017)

Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis
por: Kawamura, Kodai, et al.
Publicado: (2016)

Alkaline Phosphatase and Hypophosphatasia
por: Millán, José Luis, et al.
Publicado: (2015)

Tyrosine Kinases and Phosphatases: Enablers of the Porphyromonas gingivalis Lifestyle
por: Lamont, Richard J., et al.
Publicado: (2022)

Probing the Origins of Catalytic Discrimination between Phosphate and Sulfate Monoester Hydrolysis: Comparative Analysis of Alkaline Phosphatase and Protein Tyrosine Phosphatases
por: Andrews, Logan D., et al.
Publicado: (2014)

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
por: Stanchina, Michele, et al.
Publicado: (2020)

Extreme elevations of alkaline phosphatase in pregnancy: A case report
por: Stanley, Zachary, et al.
Publicado: (2020)

Serum Alkaline Phosphatase in Cryptogenic Stroke Cases with Active Cancer
por: Izumi, Tesseki, et al.
Publicado: (2022)

A Scoring System with High-Resolution Computed Tomography to Predict Drug-Associated Acute Respiratory Distress Syndrome: Development and Internal Validation
por: Anan, Keisuke, et al.
Publicado: (2019)

The ROX index (Index combining the respiratory rate with oxygenation) is a prognostic factor for acute respiratory distress syndrome
por: Nishiyama, Kenta, et al.
Publicado: (2023)

Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia
por: Ichikado, Kazuya, et al.
Publicado: (2021)

THE ROLE OF ALKALINE PHOSPHATASE IN OSTEOGENESIS
por: Siffert, Robert S.
Publicado: (1951)

HISTORADIOGRAPHIC IDENTIFICATION OF ALKALINE PHOSPHATASE
por: Hale, Arthur J.
Publicado: (1961)

Alkaline Phosphatase in Stem Cells
por: Štefková, Kateřina, et al.
Publicado: (2015)

Multiple Myeloma and Alkaline Phosphatase
por: Yavaşoğlu, İrfan, et al.
Publicado: (2015)

Alkaline Phosphatase in Bone Tumours
por: Chitre, R. G.
Publicado: (1943)

An mTOR feedback loop mediates the ‘flare’ (‘rebound’) response to MET tyrosine kinase inhibition
por: Altintas, D. M., et al.
Publicado: (2023)

The flare-up phenomenon: recurrence of distant dermatitis during patch testing
por: Obtułowicz, Aleksander, et al.
Publicado: (2016)

Flare-Up Phenomenon of Intradermal Test with Anaphylactic Reaction to Paracetamol (Acetaminophen)
por: Rodríguez-Fernández, Ana, et al.
Publicado: (2019)

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
por: Matsumura, Sosuke, et al.
Publicado: (2023)

Off-target effects of protein tyrosine phosphatase inhibitors on oncostatin M-treated human epidermal keratinocytes: the phosphatase targeting STAT1 remains unknown
por: Hong, Brian V., et al.
Publicado: (2020)

Impaired development of V gamma 3 dendritic epidermal T cells in p56lck protein tyrosine kinase-deficient and CD45 protein tyrosine phosphatase- deficient mice
Publicado: (1995)

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
por: Ismail, Mohamed A., et al.
Publicado: (2021)

Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
por: Mattila, Elina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f2g3o287i39trr3plu6a36r4un